Robert F. Kennedy Jr., a member of the Centers for Disease Control and Prevention's vaccine advisory panel, is pushing to delay the recommended dose of hepatitis B vaccine at birth. The move could limit children's access to this crucial protection against a virus that can lead to liver cancer.
The hepatitis B virus is transmitted through blood and bodily fluids, even in microscopic amounts. Before vaccines became available in the 1980s, McMahon, a liver specialist who has spent decades treating patients with the disease, saw young lives cut short by the virus. He remembers an 8-year-old boy who complained of stomach pain before discovering he had developed a rapidly growing tumor on his liver.
While hepatitis B can be transmitted through direct contact, it is also highly contagious, even when infected individuals are asymptomatic. McMahon has cared for children who tested negative at birth but later became infected through indirect contact. He attributes the virus's high infectiousness to its ability to survive on surfaces for a week and spread quickly through tiny amounts of blood.
The Centers for Disease Control and Prevention recommends that all pregnant people be screened for hepatitis B, but it estimates that up to 16% are not tested. If private insurers cover the vaccine, misinformation from Kennedy's meeting could still lead families to believe the vaccine harms their babies, according to Dr. Sean O'Leary, chair of the Committee on Infectious Diseases for the American Academy of Pediatrics.
The three-dose hepatitis B vaccine has a proven track record of safety, with numerous studies showing it does not increase the risk of infant death or serious reactions. In fact, the vaccine has saved countless lives by preventing liver cancer in children who receive all three doses. The CDC estimates that 2.4 million people in the U.S. have hepatitis B and that half do not know they are infected.
As experts warn, delaying the recommended dose could lead to more cases of the disease circulating in American communities, increasing the risk of contraction for those who don't get vaccinated. This, in turn, can result in higher medical costs for patients and the broader healthcare system.
If you're an expectant parent considering whether or not to give your newborn the hepatitis B vaccine, Dr. William Schaffner advises talking to your doctor about the risks and benefits. The vaccine is crucial in preventing liver cancer, which can be deadly if left untreated. Schaffner emphasizes that even if a pregnant woman tests negative for the virus, it's still essential to administer the birth dose to prevent infection.
Ultimately, as more countries model this program on the U.S. approach, it becomes clear that delaying the recommended dose of hepatitis B vaccine at birth is not an advisable move.
The hepatitis B virus is transmitted through blood and bodily fluids, even in microscopic amounts. Before vaccines became available in the 1980s, McMahon, a liver specialist who has spent decades treating patients with the disease, saw young lives cut short by the virus. He remembers an 8-year-old boy who complained of stomach pain before discovering he had developed a rapidly growing tumor on his liver.
While hepatitis B can be transmitted through direct contact, it is also highly contagious, even when infected individuals are asymptomatic. McMahon has cared for children who tested negative at birth but later became infected through indirect contact. He attributes the virus's high infectiousness to its ability to survive on surfaces for a week and spread quickly through tiny amounts of blood.
The Centers for Disease Control and Prevention recommends that all pregnant people be screened for hepatitis B, but it estimates that up to 16% are not tested. If private insurers cover the vaccine, misinformation from Kennedy's meeting could still lead families to believe the vaccine harms their babies, according to Dr. Sean O'Leary, chair of the Committee on Infectious Diseases for the American Academy of Pediatrics.
The three-dose hepatitis B vaccine has a proven track record of safety, with numerous studies showing it does not increase the risk of infant death or serious reactions. In fact, the vaccine has saved countless lives by preventing liver cancer in children who receive all three doses. The CDC estimates that 2.4 million people in the U.S. have hepatitis B and that half do not know they are infected.
As experts warn, delaying the recommended dose could lead to more cases of the disease circulating in American communities, increasing the risk of contraction for those who don't get vaccinated. This, in turn, can result in higher medical costs for patients and the broader healthcare system.
If you're an expectant parent considering whether or not to give your newborn the hepatitis B vaccine, Dr. William Schaffner advises talking to your doctor about the risks and benefits. The vaccine is crucial in preventing liver cancer, which can be deadly if left untreated. Schaffner emphasizes that even if a pregnant woman tests negative for the virus, it's still essential to administer the birth dose to prevent infection.
Ultimately, as more countries model this program on the U.S. approach, it becomes clear that delaying the recommended dose of hepatitis B vaccine at birth is not an advisable move.